Coloplast A/S (OTCMKTS:CLPBY – Get Rating) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 19,100 shares, a growth of 365.9% from the April 15th total of 4,100 shares. Based on an average daily trading volume, of 220,500 shares, the short-interest ratio is currently 0.1 days.
Coloplast A/S stock opened at $12.10 on Thursday. The stock has a market cap of $26.14 billion, a price-to-earnings ratio of 40.33 and a beta of 0.28. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.29 and a quick ratio of 0.90. Coloplast A/S has a 1 year low of $11.84 and a 1 year high of $18.90. The firm has a 50-day moving average of $14.43 and a two-hundred day moving average of $15.44.
A number of equities analysts recently commented on the stock. DNB Markets raised shares of Coloplast A/S from a “sell” rating to a “hold” rating in a research note on Wednesday, January 26th. JPMorgan Chase & Co. dropped their price target on shares of Coloplast A/S from 1,014.00 to 980.00 and set a “neutral” rating for the company in a research note on Tuesday. One analyst has rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $1,038.00.
About Coloplast A/S (Get Rating)
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.